Product Information

BENZONATATE 200 MG CAPSULE is a generic product labeled by TAGI Pharma Inc., priced at $0.1062 per EA under NDC 51224000160. Its NADAC has been published 436 times since Nov 2, 2016.

The High Outlier badge above means this manufacturer's average price in the Benzonatate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BENZONATATE 200 MG CAPSULE

Benzonatate
$0.1062per EA
High Outlier

Strength

200 mg/1

Manufacturer

TAGI Pharma Inc.

NDC

51224000160

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

2/19/2025

Active Ingredients

BENZONATATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202765

On Market Since

8/10/2015

Pharmacological Classes

Decreased Tracheobronchial Stretch Receptor Activity
Non-narcotic Antitussive

Price Statistics

The NADAC for BENZONATATE 200 MG CAPSULE has been published 436 times since Nov 2, 2016, and over the history we have for it it has declined 69.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1062 per EA
All-time high$0.3557 (Jan 11, 2017)
All-time low$0.0829 (Nov 20, 2024)
Median price$0.1394
Average price$0.1665
Largest weekly change-30.2% (Nov 20, 2024)
Weeks tracked436
Tracking sinceNov 2, 2016

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-5.0%

5Y

-21.0%

All

-69.2%

Generic Alternatives

The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BENZONATATE 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BENZONATATE 200 MG CAPSULE, manufactured by TAGI Pharma Inc., is $0.1062 per EA (NDC 51224000160), effective Mar 5, 2025.

How has the price of BENZONATATE 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BENZONATATE 200 MG CAPSULE has declined 69.2%. It has been tracked across 436 weekly CMS publications since Nov 2, 2016.

What are the highest and lowest recorded NADAC prices for BENZONATATE 200 MG CAPSULE?

Since Nov 2, 2016, the NADAC for BENZONATATE 200 MG CAPSULE has ranged from a low of $0.0829 (Nov 20, 2024) to a high of $0.3557 (Jan 11, 2017), with a median of $0.1394 per EA.

Are there cheaper alternatives to BENZONATATE 200 MG CAPSULE?

Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BENZONATATE 200 MG CAPSULE, is $0.1046 per EA — about 1% below BENZONATATE 200 MG CAPSULE.

Who manufactures BENZONATATE 200 MG CAPSULE?

BENZONATATE 200 MG CAPSULE (NDC 51224000160) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.